|
|
Volumn 6, Issue 2, 1999, Pages 403-407
|
|
Bcl-2 protein in human myeloid leukaemia cells and its down-regulation during chemotherapy-induced apoptosis.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD34 ANTIGEN;
CYTARABINE;
DRUG DERIVATIVE;
FLUDARABINE;
LEUKOCYTE ANTIGEN;
PROTEIN BCL 2;
VIDARABINE;
ACUTE DISEASE;
APOPTOSIS;
ARTICLE;
CELL STRAIN U937;
DRUG EFFECT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENETICS;
HUMAN;
METABOLISM;
MYELOID LEUKEMIA;
PHYSIOLOGY;
PROTO ONCOGENE;
ACUTE DISEASE;
ANTIGENS, CD;
ANTIGENS, CD34;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CYTARABINE;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GENES, BCL-2;
HUMANS;
LEUKEMIA, MYELOID;
PROTO-ONCOGENE PROTEINS C-BCL-2;
U937 CELLS;
VIDARABINE;
|
|
EID: 0033091921
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.6.2.403 Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|
